Switzerland· 65921002
Descovy
A emtricitabine and tenofovir alafenamide product containing emtricitabinum, tenofovirum alafenamidum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine and tenofovir alafenamide is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR17 (emtricitabine and tenofovir alafenamide), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine and tenofovir alafenamide · ATC J05AR17
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- emtricitabinum, tenofovirum alafenamidum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J05AR17
- ATC class
- Emtricitabine and tenofovir alafenamide
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680659210024Fl 30 StkCHF 682.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine and tenofovir alafenamide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDESCOVYGilead Sciences Ireland UC, Carrigtohill
- FinlandDescovyOrifarm Oy
- SpainDESCOVY 200 MG/ 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGilead Sciences Ireland Unlimited Company
- IcelandDescovyGilead Sciences Ireland UC*
- SwedenDescovy 200 mg/10 mg Filmdragerad tablettGilead Sciences Ireland UC
- PolandDescovyGilead Sciences Ireland UC
- United StatesDESCOVYGilead Sciences, Inc.
- United KingdomDescovy 200mg/10mg tabletsGilead Sciences Ltd
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Czechia · Emtricitabine/Tenofovir Alafenamide Zentiva
- Denmark · Emtricitabin/Tenofoviralafenamid Lupin, Emtricitabine/Tenofovir Alafenamide Medical Valley
- Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys, Emtricitabina/Tenofovir Alafenamida Zentiva
- Finland · Emtricitabine/Tenofovir Alafenamide Lupin
- France · Emtricitabine/Tenofovir Alafenamide Zentiva
- United Kingdom (Northern Ireland) · Emtricitabine/Tenofovir Alafenamide Amarox, Emtricitabine/Tenofovir Alafenamide Zentiva Pharma
- Iceland · Descovy, Emtricitabine/Tenofovir Alafenamide Viatris
- Italy · Emtricitabina E Tenofovir Alafenamide Zentiva
- Liechtenstein · Descovy, Emtricitabine/Tenofovir Alafenamide Viatris
- Netherlands · Emtricitabine/Tenofovir Alafenamide Zentiva, Emtricitabine/Tenofoviralafenamide Lupin
- Norway · Descovy, Emtricitabine/ Tenofovir Alafenamide Lupin
- Portugal · Emtricitabina + Tenofovir Alafenamida Zentiva
- Sweden · Emtricitabine/ Tenofovir Alafenamide Lupin, Emtricitabine/Tenofovir Alafenamide Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cba45aac-72fd-44f4-af92-6e7162bf2728 GET /v1/drugs/cba45aac-72fd-44f4-af92-6e7162bf2728?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "emtricitabinum 200 mg + tenofovirum alafenamidum 25 mg",
"valid_from": "2017-05-01",
"limitations": null,
"galenic_form": "Filmtabl 200/25 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2017-05-01",
"self_retention_pct": 10
}See everything about emtricitabine and tenofovir alafenamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.